Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

May 28, 2025

BUY
$160.99 - $215.69 $4,024 - $5,392
25 Added 1.14%
2,210 $421 Million
Q3 2023

May 28, 2025

BUY
$194.33 - $283.97 $13,603 - $19,877
70 Added 3.31%
2,185 $435 Million
Q2 2022

May 28, 2025

SELL
$115.91 - $214.48 $1,738 - $3,217
-15 Reduced 0.7%
2,115 $404 Million
Q1 2022

May 28, 2025

BUY
$127.96 - $207.36 $3,838 - $6,220
30 Added 1.43%
2,130 $442 Million
Q2 2021

May 28, 2025

SELL
$131.45 - $201.49 $13,144 - $20,149
-100 Reduced 4.55%
2,100 $398 Million
Q1 2021

May 28, 2025

SELL
$92.73 - $142.05 $314,540 - $481,833
-3,392 Reduced 60.66%
2,200 $287 Million
Q3 2020

May 28, 2025

BUY
$42.79 - $75.8 $5,990 - $10,612
140 Added 2.57%
5,592 $424 Million
Q2 2020

May 28, 2025

BUY
$27.25 - $47.53 $148,567 - $259,133
5,452 New
5,452 $258 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Wealth Management Associates, Inc. Portfolio

Follow Wealth Management Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Management Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Management Associates, Inc. with notifications on news.